Physician profile
Brian Miller
NPI 1952668964
$27,567.33
in general payments reported to CMS, 2019-2025
31 companies · $5,809 in 2025
The $5,809 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $387 · 2021: $911 · 2022: $819 · 2023: $1,767 · 2024: $1,282 · 2025: $5,809.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,787 · Travel and Lodging: $3,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,787.04 |
| Travel and Lodging | $3,070.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $14,083.87 | 2019-2020 | |
| Abbott Laboratories | $4,009.06 | 2019-2025 | Aveir, Gallant, Assurity |
| Boston Scientific Corporation | $3,604.45 | 2020-2025 | Ingevity+, Watchman Flx, Watchman Access System |
| Biosense Webster, INC. | $3,442.44 | 2020-2025 | Carto 3, Nuvision Ice Catheter |
| Medtronic, INC. | $466.27 | 2021-2025 | Pulseselect, Affera Mapping System, Linq II |
| Atricure, INC. | $370.88 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Cardiva Medical, INC. | $297.03 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Cvrx, INC. | $220.26 | 2022-2025 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $172.01 | 2021-2025 | Lifevest |
| Medical Device Business Services, INC. | $96.15 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $88.40 | 2021-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.35 | 2021-2023 | Jardiance |
| Edwards Lifesciences Corporation | $72.67 | 2023-2024 | Hemosphere |
| Philips North America LLC | $66.03 | 2022-2024 | (5091) Amb Mon & Diag Und |
| Merck Sharp & Dohme LLC | $65.73 | 2021-2024 | Verquvo |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $43.10 | 2021-2025 | |
| Abiomed | $41.23 | 2025 | |
| Biotronik INC. | $40.14 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $38.37 | 2021-2022 | |
| Shockwave Medical, INC | $37.84 | 2025 | |
| Cordis US Corp. | $35.24 | 2025 | Mynx Control Venous |
| Lexicon Pharmaceuticals, INC. | $31.18 | 2024 | |
| Impulse Dynamics (USA) INC. | $25.63 | 2022 | |
| Kestra Medical Technology Services, INC. | $23.69 | 2023 | Assure Wcd |
| Bayer Healthcare Pharmaceuticals INC. | $22.35 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.11 | 2024 | Xarelto |
| Lundbeck LLC | $16.81 | 2021 | |
| Amgen INC. | $14.21 | 2022 | |
| Davol INC. | $13.33 | 2021 | |
| Irhythm Technologies, INC. | $13.30 | 2023 | Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $13.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.